Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study
- PMID: 35462041
- PMCID: PMC9021127
- DOI: 10.1016/j.diabet.2022.101351
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study
Abstract
Aim: Individuals with SARS-CoV-2 infection and (pre-existing) diabetes, including pregnant women, present with more severe morbidity, as compared to non-diabetic subjects. To date, evidence is limited concerning the role of gestational diabetes (GDM) in severity of SARS-CoV-2 infection during pregnancy, or vice versa. The aim of our study was to investigate the prevalence of GDM in a SARS-CoV-2 infected pregnant population and evaluate risk factors for and from severe infection in these patients.
Methods: A case-control study with prospective data collection for the case group and 1:2 matching with historical controls based on parity, BMI and ethnicity was conducted (n = 224). GDM screening was performed at 26 weeks' gestation. Multivariate binary logistic regression analysis was performed to assess risk factors for GDM and inpatient COVID-19 management.
Results: 34.6% of the patients in the case group suffered from GDM, vs. 16.1% in the control group (p = 0.002). 35.7% patients were diagnosed with GDM after, vs. 33.3% before SARS-CoV-2 infection (OR (95%CI) 1.11(0.40-3.08), p = 0.84), with no correlation between time point of infection and GDM diagnosis. SARS-CoV-2 (OR (95%CI) 2.79 (1.42, 5.47), p = 0.003) and BMI (OR (95%CI) 1.12 (1.05, 1.19), p = 0.001) were significant independent risk factors for GDM.
Conclusion: Data suggests that GDM increases the risk of infection in SARS-CoV-2 infected pregnant women. Meanwhile, SARS-CoV-2 during pregnancy might increase the risk of developing GDM. Vaccination and caution in using protective measures should be recommended to pregnant women, particularly when suffering from GDM.
Keywords: COVID-19; Gestational diabetes; SARS-CoV-2.
Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
References
-
- Hartmann-Boyce J., Rees K., Perring J.C. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews. Diabetes Care. 2021;44(12):2790–2811. doi: 10.2337/dc21-0930. Epub 2021 Oct 28. Erratum in: Diabetes Care. 2022 Mar 09; PMID: 34711637; PMCID: PMC8669527. - DOI - PMC - PubMed
-
- Radan A.P., Baud D., Favre G., Papadia A., Surbek D., Baumann M., Raio L. Low placental weight and altered metabolic scaling after severe acute respiratory syndrome coronavirus type 2 infection during pregnancy: a prospective multicentric study. Clin Microbiol Infect. 2022 doi: 10.1016/j.cmi.2022.02.003. Feb 10:S1198-743X(22)00076-3 Epub ahead of print. PMID: 35150886; PMCID: PMC8828389. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
